JPRN-UMIN000013363已完成未知
tility of fecal calprotectin in patients with Crohn's disease - Utility of fecal calprotectin in CD patients
ational Defense Medical College Hospital second internal medicine0 个研究点目标入组 25 人开始时间: 2014年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The duration of each examinations is more than two weeks. The therapy changed during each examinations. Disease activity changed during each examinations.
研究者
相似试验
招募中
Unknown
Study on the usefulness of fecal calprotectin in ulcerative colitis and the relevance of other biomarkerslcerative colitisJPRN-UMIN000052832Ehime University150
Unknown
不适用
Fecal Calprotectin as a Marker for Macroscopic Recurrence of Crohn's Disease After Intestinal ResectionComplicated Crohn's DiseaseNCT00922415Tel-Aviv Sourasky Medical Center100
已完成
不适用
The value of faecal calprotectin (CPT) in monitoring the response to treatment of patients with inflammatory bowel diseaseInflammatory bowel diseaseDigestive SystemCrohn's disease [regional enteritis]ISRCTN81965907Department of Health (UK)80
招募中
不适用
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot study10017966colitisNL-OMON42995ederlands Kanker Instituut50
已完成
不适用
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54